Lifecore Biomedical, Inc. \De\ (LFCR) Change in Account Payables (2016 - 2025)
Lifecore Biomedical, Inc. \De\ has reported Change in Account Payables over the past 16 years, most recently at $1.0 million for Q2 2025.
- Quarterly results put Change in Account Payables at $1.0 million for Q2 2025, up 150.7% from a year ago — trailing twelve months through May 2025 was -$1.7 million (up 74.99% YoY), and the annual figure for FY2025 was -$1.7 million, up 74.99%.
- Change in Account Payables for Q2 2025 was $1.0 million at Lifecore Biomedical, Inc. \De\, up from -$3.5 million in the prior quarter.
- Over the last five years, Change in Account Payables for LFCR hit a ceiling of $13.7 million in Q4 2021 and a floor of -$12.4 million in Q2 2021.
- Median Change in Account Payables over the past 5 years was -$367500.0 (2023), compared with a mean of $28555.6.
- Biggest five-year swings in Change in Account Payables: surged 212.34% in 2023 and later plummeted 4708.47% in 2024.
- Lifecore Biomedical, Inc. \De\'s Change in Account Payables stood at $13.7 million in 2021, then dropped by 18.67% to $11.1 million in 2022, then tumbled by 100.53% to -$59000.0 in 2023, then plummeted by 4708.47% to -$2.8 million in 2024, then surged by 136.8% to $1.0 million in 2025.
- The last three reported values for Change in Account Payables were $1.0 million (Q2 2025), -$3.5 million (Q1 2025), and -$2.8 million (Q4 2024) per Business Quant data.